CompletedNot Applicable

Evaluation of Intestinal Secretion of Antibodies and Auto-antibodies Associated With Crohn's Disease

France160 participantsStarted 2008-06

Plain-language summary

We propose to study the intestinal secretion of ASCA by evaluating them in biopsy culture supernatants from a cohort of patients suffering from CD (n=80) and a cohort of control patients (UC (n=40) and patients without IBD (n=40 )).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients reached by disease of crohn * patients reached by hemorrhagic first side-colitis Exclusion Criteria: * Forms ileales or ano-périneales pure of disease of crohn * indefinite colitis

What they're measuring

Compare the performances of the dosage of the ASCA in floating it of culture of intestinal biopsies in that of their dosage in the serum

Timeframe: 24 months

Trial details

NCT IDNCT00769236

SponsorAssistance Publique Hopitaux De Marseille

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2010-05

View on ClinicalTrials.gov More Crohn's Disease trials